Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.
Outlet:
Life-Science-Europe.com
Media Type:
Online
Wednesday, 30 August 2017